Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2001-7-20
pubmed:abstractText
A new human GR gene sequence (hGR 1Ap/e), which is distinct from the previously identified human GR promoter and coding sequences, has been isolated and characterized. The hGR 1Ap/e sequence is approximately 31 kbp upstream of the human GR coding sequence. This sequence (2,056 bp) contains a novel promoter (the hGR 1A promoter; 1,075 bp) and untranslated exon sequence (hGR exon 1A sequence; 981 bp). Alternative splicing produces three different hGR 1A-containing transcripts, 1A1, 1A2, and 1A3. GR transcripts containing exon 1A1, 1A2, 1B, and 1C are expressed at various levels in many cancer cell lines, while the exon 1A3-containing GR transcript is expressed most abundantly in blood cell cancer cell lines. Glucocorticoid hormone treatment causes an up-regulation of exon 1A3-containing GR transcripts in CEM-C7 T-lymphoblast cells and a down-regulation of exon 1A3-containing transcripts in IM-9 B-lymphoma cells. Deoxyribonuclease I footprinting using CEM-C7 cell nuclear extract reveals four footprints in the promoter region and two intraexonic footprints. Much of the basal promoter-activating function is found in the +41/+269 sequence, which contains two deoxyribonuclease I footprints (FP5 and FP6). When this sequence is cloned into the pXP-1 luciferase reporter gene, hormone treatment causes a significant increase in luciferase activity in Jurkat T cells that are cotransfected with a GR expression vector. FP5 is an interferon regulatory factor-binding element, and it contributes significantly to basal transcription rate, but it is not activated by steroid. FP6 resembles a glucocorticoid response element and can bind GRbeta. This novel hGR 1Ap/e sequence may have future applications for the diagnosis, prognosis, and treatment of T-cell leukemia and lymphoma.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0888-8809
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1381-95
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11463861-Alternative Splicing, pubmed-meshheading:11463861-Base Sequence, pubmed-meshheading:11463861-DNA Footprinting, pubmed-meshheading:11463861-DNA-Binding Proteins, pubmed-meshheading:11463861-Deoxyribonuclease I, pubmed-meshheading:11463861-Exons, pubmed-meshheading:11463861-Gene Expression, pubmed-meshheading:11463861-Glucocorticoids, pubmed-meshheading:11463861-Hematologic Neoplasms, pubmed-meshheading:11463861-Humans, pubmed-meshheading:11463861-Interferon Regulatory Factor-1, pubmed-meshheading:11463861-Jurkat Cells, pubmed-meshheading:11463861-Lymphoma, B-Cell, pubmed-meshheading:11463861-Molecular Sequence Data, pubmed-meshheading:11463861-Mutagenesis, Site-Directed, pubmed-meshheading:11463861-Neoplasms, pubmed-meshheading:11463861-Phosphoproteins, pubmed-meshheading:11463861-Polymerase Chain Reaction, pubmed-meshheading:11463861-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:11463861-Promoter Regions, Genetic, pubmed-meshheading:11463861-RNA, Messenger, pubmed-meshheading:11463861-Receptors, Glucocorticoid, pubmed-meshheading:11463861-Response Elements, pubmed-meshheading:11463861-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:11463861-Transfection, pubmed-meshheading:11463861-Tumor Cells, Cultured, pubmed-meshheading:11463861-Untranslated Regions
pubmed:year
2001
pubmed:articleTitle
Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids.
pubmed:affiliation
Department of Biochemistry and Molecular Biology and the Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't